The Health Economics (HE) and Real‑World Evidence (RWE) team of specialists offer a collective market access experience of approximately 70 years, ranging from academic units, the pharmaceutical industry, and consulting organisations. This is underpinned with experience in a large variety of disease areas and supporting different types of healthcare interventions such as pharmaceuticals, diagnostics, devices, and delivery of healthcare services.
We provide solutions to different types of client needs, from internal corporate decision-making and market access submissions, across all stages of an intervention’s life cycle, ranging from exploratory research to in‑market product support. This routinely involves creating a diverse array of materials, ranging from real‑world data evidence generation to building budget impact and cost‑effectiveness models.
We are part of Decision Resources Group (DRG), a subsidiary of Piramal Enterprises Ltd.
DRG offers best-in-class, high-value data, analytics and insights products and services to the healthcare industry, delivered by more than 1,000 employees across 17 offices in North America, Europe and Asia.Our Company